Skip to main content

Jonathan Huggins

Assistant Professor of Medicine
Medicine, Infectious Diseases

Current Duke Appointments & Affiliations


Assistant Professor of Medicine · 2021 - Present Medicine, Infectious Diseases, Medicine
Member of the Duke Cancer Institute · 2024 - Present Duke Cancer Institute, Institutes and Centers

Recent Scholarly Works


Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates.

Journal article Transplant Cell Ther · May 2026 Chimeric antigen receptor T-cell (CAR-T) therapy targeting B-cell maturation antigen (BCMA) has revolutionized treatment for relapsed/refractory multiple myeloma (RRMM). While life-threatening toxicities like cytokine release syndrome and immune effector c ... Full text Link to item Cite

Respiratory Viral Infections Following CD19 CAR T-Cell Therapy.

Journal article J Med Virol · May 2026 Respiratory viral infections (RVI) are an important infectious complication after chimeric antigen receptor (CAR) T-cell therapy. However, the epidemiology of RVI following CAR T-cell therapy and their risk factors are not well defined. To describe the inc ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Clinical and Applied Research Strategies for the Prevention and Control of Fungal Diseases

ResearchPrincipal Investigator · Awarded by University of Alabama at Birmingham · 2025 - 2028

F2G F901315 0041

Clinical TrialPrincipal Investigator · Awarded by F2G Ltd · 2023 - 2026

MSGERC Registry of Patients With Invasive Fungal Infections, A Prospective Multi-Site Study

ResearchInvestigator · Awarded by University of Alabama at Birmingham · 2026 - 2026

View All Grants

Education


Cornell University, Weill Medical College · 2014 M.D.